News Details

Unlocking the potential of PVRIG & TIGIT pathways to deliver the next transformational cancer immunotherapy drugs

December 8, 2022

Eran Ophir, SVP Research & Drug Discovery, Compugen, TIGIT Axis Therapies Summit, December 8, 2022